Autopsy report · NCT05220293

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Single site study OT-007 re-opened as multi-site OT-007B study”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 1 year 10 months before it stopped.
2 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Oticara Australia PTY LTD
Sponsor type: Industry
Conditions: Chronic Rhinosinusitis (Diagnosis)
Interventions: Betamethasone Dipropionate Nasal Cream 0.0644%; Pre-filled syringe and applicator device
Participants: 2
Sites: 1
Countries: Australia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.